Atrial Shunt No Benefit for Heart Failure With Preserved EF

FRIDAY, Feb. 4, 2022 (HealthDay News) -- For patients with heart failure and an ejection fraction of greater than or equal to 40 percent, placement of an atrial shunt device does not reduce the rate of heart failure events, according to a study published online Feb. 1 in The Lancet.
Sanjiv J. Shah, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues randomly assigned patients with symptomatic heart failure and an ejection fraction of at least 40 percent to either an atrial shunt device (314 patients) or sham procedure (312 patients). The primary composite outcome was cardiovascular death or nonfatal ischemic stroke at 12 months, rate of total heart failure events up to 24 months, and change in the Kansas City Cardiomyopathy Questionnaire overall summary score at 12 months.
The researchers found that the groups did not differ significantly in terms of the primary composite end point (win ratio, 1.0; 95 percent confidence interval, 0.8 to 1.2; P = 0.85) or in the individual components of the composite end point. A differential effect of atrial shunt device treatment on heart failure events was seen in prespecified subgroups of pulmonary artery systolic pressure at 20W of bicycle exercise, right atrial volume index, and sex (worse outcomes for >70 mm Hg, ≥29.7 mL/m2, and men, respectively).
"While the overall trial was neutral, in our subgroup analyses, we found that what happens in the heart and lungs during exercise is of prime importance in this type of heart failure," Shah said in a statement.
Several authors disclosed financial ties to pharmaceutical and medical device companies, including Corvia Medical, which funded the study.
Abstract/Full Text (subscription or payment may be required)
Related Posts
¿Los medicamentos para el TDAH podrían ayudar a tratar el Alzheimer?
JUEVES, 7 de julio de 2022 (HealthDay News) -- ¿Podrían unos medicamentos para...
Endocrine Society, June 11-14
The annual meeting of the Endocrine Society was held from June 11 to 14 in...
Nicotinamide Does Not Prevent Keratinocyte Cancers in Organ Recipients
FRIDAY, March 17, 2023 (HealthDay News) -- Oral nicotinamide (vitamin B3)...
Cuando la paciente es una mujer y el cirujano un hombre, hay más probabilidades de un mal resultado: estudio
LUNES, 13 de diciembre de 2021 (HealthDay News) -- No siempre puede elegir quién...